Klaviyo KVYO Q1 2026 Beat Revenue NA EPS Exceeds by Significant Silo Pharma SILO Q4 2023 Earnings Miss Sparks Concern Treasure Global TGL Reports Strong Q3 2024 Revenue NA EPS Beats Arcadia Biosciences RKDA Crushes Q3 2025 Estimates EPS 062 Tops Views